Registration
DELAHUNT GROUP, LLC for HEALIANCE PHARMACEUTICALS
Firm
Client
Income
—
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
innovative diabetes treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT New | Member of the U.S. House of Representatives |
Health Issues HCR
innovative diabetes treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT New | Member of the U.S. House of Representatives |
Foreign Relations FOR
innovative diabetes treatment
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM DELAHUNT New | Member of the U.S. House of Representatives |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| DIGEN PHARMACEUTICALS GMBH | Austria | Austria | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.